These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30422158)

  • 1. Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.
    Kugathasan P; Horsdal HT; Aagaard J; Jensen SE; Laursen TM; Nielsen RE
    JAMA Psychiatry; 2018 Dec; 75(12):1234-1240. PubMed ID: 30422158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care.
    Vanasse A; Courteau J; Niyonsenga T
    BMC Cardiovasc Disord; 2006 May; 6():21. PubMed ID: 16674817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease.
    Krause MW; Massing M; Kshirsagar A; Rosamond W; Simpson RJ
    Ren Fail; 2004 Nov; 26(6):715-25. PubMed ID: 15600265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality.
    Hamood H; Hamood R; Green MS; Almog R
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1093-104. PubMed ID: 26183333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
    Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
    Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: a nationwide registry-based study.
    Smedegaard L; Charlot MG; Gislason GH; Hansen PR
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):93-101. PubMed ID: 28510644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.
    Zaman MJ; Fleetcroft R; Bachmann M; Sarev T; Stirling S; Clark A; Myint PK
    Age Ageing; 2016 Jan; 45(1):96-103. PubMed ID: 26601697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Use of Cardioprotective Medication in Peripheral Artery Disease: A Nationwide Study.
    Kamil S; Sehested TSG; Houlind K; Lassen JF; Gislason GH; Dominguez H
    J Am Heart Assoc; 2021 Aug; 10(15):e020333. PubMed ID: 34315233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.
    Zullo AR; Mogul A; Corsi K; Shah NR; Lee SJ; Rudolph JL; Wu WC; Dapaah-Afriyie R; Berard-Collins C; Steinman MA
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e004942. PubMed ID: 31002274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
    Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses.
    Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Thuesen L; Thayssen P; Tilsted HH; Jørgensen E; Galatius S
    Eur J Prev Cardiol; 2012 Aug; 19(4):746-54. PubMed ID: 21724682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.